Chromadex Corp Company Insiders
CDXC Stock | USD 7.59 0.13 1.74% |
About 66 percent of all Chromadex Corp's insiders are acquiring. The analysis of insiders' sentiment of trading Chromadex Corp stock suggests that quite a large number of insiders are confidant at this time. Chromadex Corp employs about 106 people. The company is managed by 16 executives with a total tenure of roughly 12 years, averaging almost 0.0 years of service per executive, having 6.63 employees per reported executive.
Frank Jaksch CEO Co-Founder, CEO and President and Director |
Chromadex Corp's Insider Buying Vs Selling
66
Selling | Buying |
Latest Trades
2024-11-22 | Ozan Pamir | Acquired 2907 @ 7.36 | View | ||
2024-08-23 | Kristin Patrick | Disposed 23000 @ 3.57 | View | ||
2023-12-01 | Brianna Gerber | Acquired 5000 @ 1.41 | View |
Monitoring Chromadex Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Chromadex |
Chromadex Corp's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Chromadex Corp's future performance. Based on our forecasts, it is anticipated that Chromadex will maintain a workforce of about 110 employees by December 2024.Chromadex Corp Management Team Effectiveness
As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Chromadex Corp's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 28.4 M. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.As of November 26, 2024, Common Stock Shares Outstanding is expected to decline to about 43.1 M. In addition to that, Net Loss is expected to decline to about (15.6 M)
Chromadex Corp Workforce Comparison
Chromadex Corp is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,234. Chromadex Corp holds roughly 106 in number of employees claiming about 9% of equities under Health Care industry.
Chromadex Corp Profit Margins
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.35 | 0.6076 |
|
|
Chromadex Corp Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chromadex Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chromadex Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Chromadex Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 0.75 | 3 | 4 | 11,431,715 | 11,454,715 |
2024-03-01 | 2.0 | 2 | 1 | 613,454 | 58,097 |
2023-09-01 | 2.0 | 2 | 1 | 3,490,214 | 22,436 |
2023-03-01 | 1.0 | 2 | 2 | 470,362 | 98,795 |
2022-09-01 | 5.0 | 5 | 1 | 1,236,497 | 0.00 |
2022-03-01 | 2.0 | 4 | 2 | 495,627 | 43,000 |
2021-12-01 | 2.0 | 2 | 1 | 80,000 | 250,000 |
2021-03-01 | 0.8571 | 6 | 7 | 176,954 | 345,800 |
2020-12-01 | 1.0 | 2 | 2 | 46,667 | 79,496 |
2020-06-01 | 7.0 | 7 | 1 | 121,000 | 500,000 |
2020-03-01 | 3.5 | 7 | 2 | 749,467 | 54,652 |
2019-12-01 | 1.0 | 1 | 1 | 10,000 | 30,000 |
2019-03-01 | 3.5 | 14 | 4 | 695,120 | 67,724 |
2018-09-01 | 1.0 | 1 | 1 | 5,000 | 50,000 |
2018-03-01 | 1.0 | 8 | 8 | 1,023,431 | 106,862 |
2017-12-01 | 2.0 | 4 | 2 | 2,123,440 | 116,800 |
2017-09-01 | 3.0 | 6 | 2 | 2,057,417 | 28,140 |
2017-06-01 | 3.0 | 9 | 3 | 6,446,814 | 0.00 |
2016-12-01 | 6.0 | 6 | 1 | 122,000 | 10,000 |
2016-09-01 | 5.0 | 5 | 1 | 221,500 | 8,334 |
2016-06-01 | 2.0 | 2 | 1 | 7,800 | 0.00 |
2015-09-01 | 11.0 | 11 | 1 | 1,350,000 | 0.00 |
2014-03-01 | 10.0 | 10 | 1 | 1,290,000 | 200,000 |
2013-06-01 | 2.5 | 10 | 4 | 2,343,769 | 2,203,569 |
2013-03-01 | 0.8 | 4 | 5 | 2,421,428 | 3,171,428 |
2012-12-01 | 0.4074 | 11 | 27 | 4,244,807 | 6,774,012 |
2012-03-01 | 5.0 | 10 | 2 | 5,566,664 | 0.00 |
2011-12-01 | 1.3333 | 4 | 3 | 41,000 | 5,400 |
2011-09-01 | 1.0 | 2 | 2 | 6,850,002 | 6,850,002 |
2010-06-01 | 0.1579 | 3 | 19 | 293,750 | 5,825,456 |
2008-12-01 | 0.5 | 1 | 2 | 6,225,155 | 6,225,155 |
Chromadex Corp Notable Stakeholders
A Chromadex Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chromadex Corp often face trade-offs trying to please all of them. Chromadex Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chromadex Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Frank Jaksch | Co-Founder, CEO and President and Director | Profile | |
Ozan CFA | CFO Officer | Profile | |
James Lee | Principal CFO | Profile | |
Brianna Gerber | Senior Director of FP&A, IR Contact Officer | Profile | |
Robert Fried | Independent Director | Profile | |
Kendall Knysch | Head Partnerships | Profile | |
Heather Blarcom | Senior Secretary | Profile | |
Andrew Shao | Senior Affairs | Profile | |
Chu Yan | Managing Pacific | Profile | |
David Kroes | Senior Matters | Profile | |
Jason Campbell | Senior Development | Profile | |
Michiko Kelley | Chief Officer | Profile | |
Alex Worsham | Vice Communications | Profile | |
Tom Shumaker | Managing Advisors | Profile | |
Fadi Karam | Chief Officer | Profile | |
Carlos Lopez | Senior Counsel | Profile |
About Chromadex Corp Management Performance
The success or failure of an entity such as Chromadex Corp often depends on how effective the management is. Chromadex Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chromadex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chromadex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.09) | (0.10) | |
Return On Capital Employed | (0.16) | (0.17) | |
Return On Assets | (0.09) | (0.09) | |
Return On Equity | (0.17) | (0.18) |
Please note, the presentation of Chromadex Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chromadex Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chromadex Corp's management manipulating its earnings.
Chromadex Corp Workforce Analysis
Traditionally, organizations such as Chromadex Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chromadex Corp within its industry.Chromadex Corp Manpower Efficiency
Return on Chromadex Corp Manpower
Revenue Per Employee | 788.4K | |
Revenue Per Executive | 5.2M | |
Net Loss Per Employee | 46.6K | |
Net Loss Per Executive | 308.6K | |
Working Capital Per Employee | 272.8K | |
Working Capital Per Executive | 1.8M |
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |